DS
Dhiraj Singh
Texas Biomedical Research Institute, Tulane National Primate Research Center, International Centre For Genetic Engineering and Biotechnology New Delhi, Hemwati Nandan Bahuguna Garhwal University
Employment
-
Texas Biomedical Research Institute POST DOCTORAL SCIENTIST III2019 - Present
-
Tulane National Primate Research Center POST DOCTORAL FELLOW2018 - 2018
-
Jawaharlal Nehru University POST DOCTORAL FELLOW2016 - 2018
-
International Centre For Genetic Engineering and Biotechnology New Delhi SENIOR RESEARCH FELLOW2013 - 2016
-
International Centre For Genetic Engineering and Biotechnology New Delhi JUNIOR RESEARCH FELLOW2011 - 2013
Education
-
International Centre For Genetic Engineering and Biotechnology New Delhi PhD2011 - 2016
-
Hemwati Nandan Bahuguna Garhwal University M.Sc Biotechnology2009 - 2011
-
University of Calcutta B.Sc in ZOOLOGY2006 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate Save
- Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection Save
- Prevention of TB in nonhuman primates by a stress-response deficient mutant of Mycobacterium tuberculosis via induction of classical T cell immunity Save
- Immune Responses in Lung Granulomas during Mtb/HIV Co-Infection: Implications for Pathogenesis and Therapy Save
- Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy Save
- Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs Save
- Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples Save
- Peripheral Blood Markers Correlate with the Progression of Active Tuberculosis Relative to Latent Control of Mycobacterium tuberculosis Infection in Macaques Save
- Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 Save
- Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model Save